Moderna reported falling fourth-quarter sales as Covid-19 vaccine demand continued to drop, but continues to target 10% revenue growth in 2026 following the launch of its next-generation Covid vaccine.
Source link
Moderna Reiterates 10% Revenue-Growth Target as Covid Vaccine Demand Falls
Date:
More like thisRelated
MALEVOLENCE Surprise-Release Vulnerable New Ballad “Silhouette” For Valentine’s Day
Ever since their formation, Sheffield bruisers Malevolence have done...
Robovan Firm Zelos’s Tech Ambitions Get Boost From Alibaba Deal
While many in the industry zero in on turning...
U.S. women’s hockey tops Italy 6-0 to advance to Winter Olympics semifinals
The upstart Italians didn't make...